Carlsmed, Inc. Cash and Cash Equivalents
Carlsmed, Inc. (CARL) had Cash and Cash Equivalents of $46.24 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-05
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $46.24M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $73.02M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $85.79M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $115.37M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $46.24M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $73.02M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $85.79M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $115.37M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $33.47M 10-Q · filed 2026-08-05 |
| 2025-03-31 | $43.43M 10-Q · filed 2026-05-05 |
| 2024-12-31 | $40.13M 10-Q · filed 2026-08-05 |
| 2024-09-30 | $44.44M 10-Q · filed 2025-11-06 |
| 2024-06-30 | $38.15M 10-Q · filed 2025-08-28 |
| 2023-12-31 | $7.22M 10-K · filed 2026-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |